Antitumor immunity is initiated when dendritic cells capture tumor-associated antigens and present them to CD8+ T cells, which then become activated, migrate to the tumor site, and specifically target and destroy tumor cells [245]. The gene discussed is CD8A; the disease is neoplasm.